A mid-sized insurance company spent four months evaluating platforms for a new claims intake tool. They talked to three vendors. All three were the same three vendors everyone talks to, the ones that show up first in every analyst report and every LinkedIn ad. The team picked one, signed a multi-year contract, and got to work.
Eighteen months in, the CTO pulled up the licensing costs during a budget review and asked a question nobody had asked during procurement: did we actually need this much platform, or did we just default to the name we recognized?
That question is more common than most vendors would like. And it’s worth sitting with, because the answer usually isn’t flattering.
Recognition is not the same as fit
There’s a reason certain platforms dominate the conversation whenever someone mentions building enterprise applications fast. They’re capable, well-funded, and heavily marketed to procurement teams who want a name that won’t get questioned by the board. None of that is a knock against them. It’s just a different thing from being the right choice for a specific build.
A regional credit union doesn’t need the same platform as a logistics company running freight optimization across six states. But both often end up evaluating the same shortlist, because that shortlist is what shows up when someone searches for enterprise development platforms and clicks the first four results. The market has trained buyers to treat brand recognition as a proxy for suitability. It rarely is.
This is where low-code tools similar to OutSystems have quietly built a real following. Platforms like Mendix, Retool, or Appian solve overlapping problems but with different assumptions baked in about team size, deployment complexity, and how much custom code your developers actually want to write versus how much they want handled for them. A team of four developers building an internal inventory tool has almost nothing in common, operationally, with a five-hundred-person IT department building a customer-facing insurance portal. Yet both get pointed toward the same handful of platforms by default.
Healthcare makes the stakes obvious
Nowhere does this default-to-the-familiar habit cost more than in clinical settings. Healthcare software product development carries constraints that most enterprise IT teams simply don’t deal with: HIPAA, interoperability standards like HL7 and FHIR, audit trails that regulators actually check, and integration requirements with EHR systems that were never built to talk to anything modern.
A big-name platform’s generic compliance certification does not mean it handles a specific hospital’s referral workflow well. I’ve watched a hospital system spend a year integrating a widely-used low-code platform with its Epic instance, only to discover that the platform’s out-of-box healthcare templates assumed data structures that didn’t match their actual patient intake forms. The fix required custom development anyway, which defeated most of the reason they’d chosen a low-code approach in the first place.
Smaller or more specialized vendors, meanwhile, sometimes build specifically around FHIR-native data models or pre-built HL7 connectors because that’s their entire market. They’re not trying to be everything to everyone. That focus shows up in fewer workarounds later.
Why teams default to the familiar anyway
Part of it is risk aversion dressed up as due diligence. Choosing a platform nobody on the board has heard of feels like a career risk even when it’s the better technical fit. Part of it is simple inertia. Procurement teams build vendor shortlists once and reuse them for years, updating logos but rarely questioning the underlying list.
There’s also a genuine information gap. Comparing platforms on paper tells you almost nothing about how they behave with your actual data, your actual compliance requirements, your actual developer skill set. Most teams only discover a mismatch after the contract is signed and the migration has started.
What a better evaluation actually looks like
Start with the constraint that matters most for the specific build, not the platform’s general reputation. If it’s healthcare, ask about FHIR support and audit logging before anything else. If it’s a citizen-developer tool for internal ops, ask how much governance the platform enforces by default, because too little turns into shadow IT chaos and too much turns into the same bottleneck you were trying to escape.
Run a real pilot with real data, not a vendor’s canned demo. Demos are built to hide the exact friction points that show up six months into production use. And talk to a customer of comparable size and industry, not just the reference customer the sales team hands you.
None of this is complicated. It just requires resisting the pull toward whatever platform already has the most name recognition in the room. That pull is strong precisely because it feels safe. It isn’t always.